MorphoSys Reports Preliminary Q2 Monjuvi U.S. Sales; Updates 2022 Guidance

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) reported preliminary second quarter Monjuvi U.S. net product sales of $23.3 million. For the full year of 2022, the company now expects Monjuvi

Related Keywords

Martinsried ,Bayern ,Germany ,Jean Paul Kress , ,Morphosys ,Reports ,Reliminary ,Monjuvi ,Sales ,Updates ,022 ,Guidance ,